LENZ
Price
$4.68
Change
+$0.02 (+0.43%)
Updated
Aug 21 closing price
Capitalization
147.05M
80 days until earnings call
Intraday BUY SELL Signals
MNPR
Price
$107.72
Change
-$3.16 (-2.85%)
Updated
Aug 21 closing price
Capitalization
723.04M
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs MNPR

LENZ vs MNPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LENZ vs. MNPR commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and MNPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (LENZ: $4.68 vs. MNPR: $107.72)
Brand notoriety: LENZ and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 49% vs. MNPR: 55%
Market capitalization -- LENZ: $147.05M vs. MNPR: $723.04M
LENZ [@Biotechnology] is valued at $147.05M. MNPR’s [@Biotechnology] market capitalization is $723.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileMNPR’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • MNPR’s FA Score: 1 green, 4 red.
According to our system of comparison, MNPR is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 2 bullish TA indicator(s).

  • LENZ’s TA Score: 4 bullish, 4 bearish.
  • MNPR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than MNPR.

Price Growth

LENZ (@Biotechnology) experienced а -1.06% price change this week, while MNPR (@Biotechnology) price change was -4.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

LENZ is expected to report earnings on Nov 11, 2026.

MNPR is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($723M) has a higher market cap than LENZ($147M). MNPR YTD gains are higher at: 64.962 vs. LENZ (-70.750). MNPR has higher annual earnings (EBITDA): -18.71M vs. LENZ (-117.98M). LENZ has more cash in the bank: 258M vs. MNPR (137M). MNPR has less debt than LENZ: MNPR (132K) vs LENZ (673K). LENZ has higher revenues than MNPR: LENZ (21M) vs MNPR (0).
LENZMNPRLENZ / MNPR
Capitalization147M723M20%
EBITDA-117.98M-18.71M631%
Gain YTD-70.75064.962-109%
P/E Ratio48.03N/A-
Revenue21M0-
Total Cash258M137M188%
Total Debt673K132K510%
FUNDAMENTALS RATINGS
MNPR: Fundamental Ratings
MNPR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LENZMNPR
RSI
ODDS (%)
Bullish Trend 6 days ago
87%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signal:
Gain/Loss:
MNPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACMTX12.760.08
+0.63%
AB All Market Real Return C
TSMDX18.030.11
+0.61%
Trillium ESG Small/Mid Cap Institutional
TSFIX17.510.07
+0.40%
Touchstone Small Cap Institutional
VINAX177.670.65
+0.37%
Vanguard Industrials Index Admiral
DHLSX31.730.11
+0.35%
Diamond Hill Long-Short I

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with LKFT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then LKFT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+0.43%
LKFT - LENZ
39%
Loosely correlated
+1.87%
MLTX - LENZ
37%
Loosely correlated
-0.69%
CELC - LENZ
36%
Loosely correlated
+3.27%
BCYC - LENZ
36%
Loosely correlated
+3.07%
KRYS - LENZ
35%
Loosely correlated
+2.84%
More

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with QNCX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-2.85%
QNCX - MNPR
36%
Loosely correlated
+5.67%
ROIV - MNPR
34%
Loosely correlated
-1.47%
TSHA - MNPR
33%
Loosely correlated
-0.33%
LENZ - MNPR
32%
Poorly correlated
+0.43%
FDMT - MNPR
31%
Poorly correlated
-1.68%
More